David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXPR
1176
DELISTED
Express, Inc.
EXPR
| $6.78M | 0.01% |
20,498
+14,361
| +234% | +$4.16M |
|
1177
Tanger
SKT
$4.42B
| $6.76M | 0.01% |
192,291
-99,407
| -34% | -$3.71M |
|
1178
Helmerich & Payne
HP
$4.21B
| $6.76M | 0.01% |
99,300
-69,144
| -41% | -$4.52M |
|
|
XLNX
1179
CALL
DELISTED
Xilinx Inc
XLNX
| $6.75M | 0.01% |
159,500
-239,100
| -60% | -$9.8M |
|
1180
CALL
Qualcomm
QCOM
$169B
| $6.74M | 0.01% |
97,200
-266,200
| -73% | -$18.8M |
|
|
GIMO
1181
DELISTED
Gigamon Inc.
GIMO
| $6.73M | 0.01% |
316,995
+65,352
| +26% | +$1.26M |
|
|
XOXO
1182
DELISTED
Xo Group Inc
XOXO
| $6.73M | 0.01% |
380,927
+12,840
| +3% | +$217K |
|
|
FCH
1183
DELISTED
Felcor Lodging Trust
FCH
| $6.72M | 0.01% |
584,885
-47,350
| -7% | -$510K |
|
1184
Incyte
INCY
$26.3B
| $6.71M | 0.01% |
73,173
+20,528
| +39% | +$1.7M |
|
|
SF
1185
Stifel
SF
$12B
| $6.7M | 0.01% |
270,554
+128,347
| +90% | +$2.96M |
|
1186
PUT
Honeywell
HON
$68.4B
| $6.7M | 0.01% |
71,448
-314,949
| -82% | -$28.8M |
|
1187
IMAX
IMAX
$2.96B
| $6.69M | 0.01% |
198,460
+96,497
| +95% | +$3.21M |
|
1188
CALL
Illumina
ILMN
$34B
| $6.68M | 0.01% |
37,008
-60,241
| -62% | -$11.3M |
|
1189
PUT
Avis
CAR
$5.13B
| $6.67M | 0.01% |
113,000
-112,300
| -50% | -$6.85M |
|
|
PARA
1190
PUT
DELISTED
Paramount Global Class B
PARA
| $6.67M | 0.01% |
110,000
-418,400
| -79% | -$24.4M |
|
1191
CALL
Cardinal Health
CAH
$55.3B
| $6.65M | 0.01% |
73,700
| – | – |
|
|
MCRL
1192
DELISTED
MICREL INC
MCRL
| $6.65M | 0.01% |
441,091
+431,027
| +4,283% | +$6.3M |
|
1193
PUT
Bristol-Myers Squibb
BMY
$139B
| $6.64M | 0.01% |
103,000
-627,900
| -86% | -$39.3M |
|
1194
CALL
Perrigo
PRGO
$2.01B
| $6.62M | 0.01% |
40,000
| – | – |
|
|
INFI
1195
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $6.62M | 0.01% |
473,576
+95,103
| +25% | +$1.45M |
|
1196
CALL
Expedia Group
EXPE
$40.6B
| $6.62M | 0.01% |
70,300
| – | – |
|
1197
Regis Corp
RGS
$66.8M
| $6.59M | 0.01% |
20,150
-8,685
| -30% | -$2.83M |
|
|
UNT
1198
DELISTED
UNIT Corporation
UNT
| $6.59M | 0.01% |
235,651
-81,033
| -26% | -$2.41M |
|
1199
MasTec
MTZ
$19.8B
| $6.53M | 0.01% |
338,179
+209,349
| +163% | +$4.19M |
|
|
STJ
1200
PUT
DELISTED
St Jude Medical
STJ
| $6.52M | 0.01% |
99,700
-34,200
| -26% | -$2.27M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.